Longitudinal NGAL and cystatin C plasma profiles present a high level of heterogeneity in a mixed ICU population
Abstract Background NGAL and Cystatin C (CysC) as biomarkers for the early detection of AKI are subject to both pathophysiological, as well as patient related heterogeneity. The aim of this study was to investigate the timeline of plasma levels of NGAL and CysC during the first seven days of ICU adm...
Main Authors: | Daniela Jou-Valencia, Meint Volbeda, Jan G. Zijlstra, Jenny E Kootstra-Ros, Jill Moser, Matijs van Meurs, Jacqueline Koeze |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2024-01-01
|
Series: | BMC Nephrology |
Subjects: | |
Online Access: | https://doi.org/10.1186/s12882-024-03477-2 |
Similar Items
-
Comparative Assessment of uNGAL, uNAG and Cystatin C As Early Biomarkers in Renal Post-Transplant Patients
by: Nikolov G., et al.
Published: (2018-12-01) -
Effect of perinatal risk factors on neutrophil gelatinase-associated lipocalin (NGAL) level in umbilical and peripheral blood in neonates
by: Agnieszka Kisiel, et al.
Published: (2017-10-01) -
Acute Kidney Injury Prediction Model Using Cystatin-C, Beta-2 Microglobulin, and Neutrophil Gelatinase-Associated Lipocalin Biomarker in Sepsis Patients
by: Susianti H, et al.
Published: (2024-03-01) -
Exploring the Utility of Urinary Creatinine Adjustment for KIM-1, NGAL, and Cystatin C for the Assessment of Kidney Function: Insights from the C-KidnEES Cohort
by: T. D. K. S. C. Gunasekara, et al.
Published: (2023-12-01) -
Serum NGAL and Cystatin C Comparison With Urinary Albumin-to-Creatinine Ratio and Inflammatory Biomarkers as Early Predictors of Renal Dysfunction in Patients With Type 2 Diabetes
by: Marcelo R. Bacci, et al.
Published: (2017-03-01)